After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Pacific Biosciences of California Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. At the end of the last regular session, the stock closed at $3.33 and fluctuated between $4.5650 as its day high and $4.3000 as its day low. The current market capitalization of Pacific Biosciences of California Inc is $892.27M. A total of 8.24 million shares were traded on the day, compared to an average of 8.43M shares.
In the most recent transaction, Meline David W bought 40,000 shares of PACB for 4.40 per share on Mar 06 ’24. After the transaction, the Director now owns 40,000 company shares. In a previous transaction on Mar 04 ’24, HENRY CHRISTIAN O sold 14,177 shares at 4.87 per share. PACB shares that the insider owns now total 2,596,670.
Among the insiders who sold shares, Van Oene Mark disposed of 9,186 shares on Mar 04 ’24 at a per-share price of $4.87. This resulted in the insider holding 1,668,826 shares of PACB after the transaction. In another insider transaction, Kim Susan G. sold 5,275 shares at $4.87 per share on Mar 04 ’24. Company shares held by the insider now total 712,260.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, PACB has a high of $14.55 and a low of $3.21.
As of this writing, PACB has an earnings estimate of -$0.27 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of -$0.24 per share and a lower estimate of -$0.3. The company reported an EPS of -$0.26 in the last quarter, which was 21.20% higher than expectations of -$0.33.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PACB is Buy with a score of 4.29.
